Eximore vs Upstream Bio

Eximore vs Upstream Bio, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eximore is on 52/100 and Upstream Bio on 61/100.

Eximore logo
EximoreBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
Try Eximore
Upstream Bio logo
Upstream BioClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Try Upstream Bio

Where each one leads

Eximore

  • agent readiness: 50/100 against 39/100

Upstream Bio

  • our overall score: 61/100 against 52/100
  • domain rating: 32/100 against 7/100
  • headcount: 75 against 7
  • funding raised: $400M against $10.0M
  • LinkedIn following: 11,799 against 89

At a glance

MeasureEximoreUpstream Bio
What it isBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
CategoryLife Sciences, Biopharmaceutical, Biotech, MedTechLife Sciences, Therapeutics, Biotech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20142021
HeadquartersTel Aviv, IsraelWaltham, United States
StatusActiveActive

Size, funding and growth

MeasureEximoreUpstream Bio
Employees775
Headcount growthLast 12 monthsNot published+43.4%
Total funding$10.0M$400M
Latest roundSeries ASeries B
LinkedIn followers8911,799

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEximoreUpstream Bio
StartupHub scoreOur 0-100 rating52/10061/100
Traction44/10059/100
Team70/10070/100
Search visibility29/10037/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteD (50/100)F (39/100)
Domain ratingLink authority, 0-1007/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEximoreUpstream Bio
HostingGoogle CloudNot detected
CDNNot detectedCloudflare
CMSWordPressWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsGoogle Tag ManagerGoogle Tag Manager

Eximore vs Upstream Bio: common questions

Which is better, Eximore or Upstream Bio?

On our 0-100 score Upstream Bio rates higher (61/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Eximore and Upstream Bio compare on the numbers?

Eximore leads on agent readiness (50/100 against 39/100). Upstream Bio leads on our overall score (61/100 against 52/100), domain rating (32/100 against 7/100), headcount (75 against 7), funding raised ($400M against $10.0M), LinkedIn following (11,799 against 89).

Read the full Eximore review and pricing or the Upstream Bio review and pricing. You can also browse other Eximore alternatives we track.